Search results for "cancer diagnosis"

25

Refine your search

Explore by Field
Browse by Techniques

Search

Selected Filters:







MILLIPLEX® MAP Human Circulating Cancer Biomarker Magnetic Bead Panel

Merck

The MILLIPLEX® MAP Human Circulating Cancer Biomarker Magnetic Bead Panel is used for the simultaneous quantification of the following Human analytes: AFP, CEA, CYFRA21-1, FGF-2, HE4, PSA Total, PSA free, HGF, IL-6, IL-8, Leptin, MIF, OPN - Osteopontin, Prolactin, SCF, SDF-1A+β, sFas, sFasL, TGFα, TNFα, TRAIL, VEGF, CA125, CA15-3, CA19-9, β-HCG

0.0/5.0
|0 Reviews












Aptio® Automation

Siemens Healthineers

Aptio® Automation combines intelligent technologies with Siemens Healthineers workflow expertise to deliver flexible solutions that advance your laboratory’s productivity. Accelerate processing and achieve consistent turnaround time using intelligent routing, single-sample flow, and primary tube sampling technologies.Improve utilization of lab resources through data-driven simulations, optimization modeling, and best practices…

5.0/5.0
|2 Reviews
Request Pricing

How-to-buy eBook

How to Buy Clinical Automation Technology

With increasing pressures on diagnostic workflows, the automation of processes — from sample through to result — is becoming a necessity in the clinical laboratory. Download this guide to learn about automated solutions for clinical applications, with insight from key opinion leaders.


Oasis™ WAX for PFAS Analysis

Waters

Extraction and concentration without the low background contamination. Per- and polyfluoroalkyl substances (PFAS) are a growing global concern. Now your lab can extract and concentrate PFAS without worrying about low background contamination through the power of Oasis WAX for PFAS Analysis, a comprehensive quality-control pre-screening test for 32 PFAS.

4.7/5.0
|1 Review



Industry News

Accurate ligand high-affinity determination

Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy